Truckee Applied Genomics Revenue and Competitors
Estimated Revenue & Valuation
- Truckee Applied Genomics's estimated annual revenue is currently $775k per year.
- Truckee Applied Genomics's estimated revenue per employee is $155,000
Employee Data
- Truckee Applied Genomics has 5 Employees.
- Truckee Applied Genomics grew their employee count by -29% last year.
Truckee Applied Genomics's People
Name | Title | Email/Phone |
---|---|---|
1 | CSO and VP Product Development | Reveal Email/Phone |
Truckee Applied Genomics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $0.3M | 2 | -78% | N/A | N/A |
#3 | $3.5M | 13 | -13% | $18M | N/A |
#4 | $1.4M | 9 | -10% | N/A | N/A |
#5 | $11.8M | 76 | 27% | N/A | N/A |
#6 | $4.2M | 27 | 13% | N/A | N/A |
#7 | $9.3M | 60 | 9% | N/A | N/A |
#8 | $300M | 199 | -13% | $53M | N/A |
#9 | $2.6M | 17 | 6% | N/A | N/A |
#10 | $0.6M | 4 | -20% | N/A | N/A |
What Is Truckee Applied Genomics?
We provide patented reagents to improve molecular tests of tissues and pathogens. Developed and manufactured in the USA. TAG-NGPMâ„¢ - Next Generation Pathogen Media - Designed to better preserve RNA fragments in a variety of pathogen samples. Ideal as a Viral Transport Media (VTM) currently used in SARS-CoV-2 sample collection in COVID-19 testing. TAG-1 | Non-Toxic Tumor Tissue Stabilization Directly Replacing Formalin * No cross-linking of cellular proteins * Excellent preservation of tissue morphology * Strong protection of cell surface antigenic components * Protection of nuclear contents including nucleic acids ** TAG-1 is a Class 1 General Reagent pursuant to 21 CFR 864.4010
keywords:N/AN/A
Total Funding
5
Number of Employees
$775k
Revenue (est)
-29%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 5 | 0% | N/A |
#2 | $0.4M | 5 | 0% | N/A |
#3 | N/A | 5 | 0% | N/A |
#4 | $0.4M | 5 | 0% | N/A |
#5 | $0.4M | 5 | 0% | N/A |